Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis

• Published in: Scientific reports Vol. 12; no. 1; p. 9024
• Main Authors: Ono, Koya, Fujiwara, Tohru, Saito, Kei, Nishizawa, Hironari, Takahashi, Noriyuki, Suzuki, Chie, Ochi, Tetsuro, Kato, Hiroki, Ishii, Yusho, Onodera, Koichi, Ichikawa, Satoshi, Fukuhara, Noriko, Onishi, Yasushi, Yokoyama, Hisayuki, Yamada, Rie, Nakamura, Yukio, Igarashi, Kazuhiko, Harigae, Hideo
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 30.05.2022; Nature Publishing Group UK; Nature Portfolio
• Subjects: 5-Aminolevulinate synthase; 5-Aminolevulinate Synthetase - genetics; Anemia; Anemia, Sideroblastic - genetics; Anemia, Sideroblastic - metabolism; Apoptosis; Biosynthesis; Cell death; Cloning; Cord blood; Erythroblasts; Ferroptosis; Ferroptosis - genetics; Genetic Diseases, X-Linked; Glutathione; Heme; Hemoglobin; Humans; Iron; Iron - metabolism; Lipid peroxidation; Metabolism; Missense mutation; Mitochondria; Mutation; Peroxidation; Sideroblastic anemia; Therapeutic targets; Umbilical cord
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-12940-9

X-linked sideroblastic anemia (XLSA), the most common form of congenital sideroblastic anemia, is caused by a germline mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene. In XLSA, defective heme biosynthesis leads to ring sideroblast formation because of excess mitochondrial iron accumulation. In this study, we introduced ALAS2 missense mutations on human umbilical cord blood-derived erythroblasts; hereafter, we refer to them as XLSA clones. XLSA clones that differentiated into mature erythroblasts showed an increased frequency of ring sideroblast formation with impaired hemoglobin biosynthesis. The expression profiling revealed significant enrichment of genes involved in ferroptosis, which is a form of regulated cell death induced by iron accumulation and lipid peroxidation. Notably, treatment with erastin, a ferroptosis inducer, caused a higher proportion of cell death in XLSA clones. XLSA clones exhibited significantly higher levels of intracellular lipid peroxides and enhanced expression of BACH1, a regulator of iron metabolism and potential accelerator of ferroptosis. In XLSA clones, BACH1 repressed genes involved in iron metabolism and glutathione synthesis. Collectively, defective heme biosynthesis in XLSA clones could confer enhanced BACH1 expression, leading to increased susceptibility to ferroptosis. The results of our study provide important information for the development of novel therapeutic targets for XLSA.